1st Quarter - Report · 2026

Filing UUID: ffa521da-1456-4f15-a60b-a4d98ed111d9
Type: Q1 — 1st Quarter - Report
Period: first_quarter
Year: 2026
Posted: 2026-04-18 20:50:05
Income (reported): $30,000
Expenses (reported): —
Filing document: Open on lda.senate.gov

Registrant (lobbying firm)

CAPITOL COUNSEL LLC

Government affairs.

Contact: TRACEY A. GRAY
Phone: +1 202-861-3200
Address: zip:20005, city:Washington, state:DC, street:700 13th Street NW, 2nd Floor

Client

AMICUS THERAPEUTICS, INC.

Biopharmaceutical company.

State: NJ
Country: US
Effective date: 2026-02-05

Issues lobbied + lobbyists

`HCR` — Health Issues

Legislative and regulatory issues affecting SMID rare disease biotech companies. FDA approvals of rare diseases.

Lobbyists: JOHN MARTIN; KAREN STONE (covered position: Legislative Director, Rep. Dina Titus (D-NV); Legislative Correspondent/Staff Assistant, Rep. Steve Israel (D-NY); Senior Legislative Assistant, Rep. Steve Israel (D-NY).) [new]; mr CHARLES PATRICK MICHAELS (covered position: Chief of Staff, Deputy Chief of Staff, Legislative Director, Senior Legislative Assistant, and Legislative Assistant, Rep. David Schweikert; Staff Assistant, Rep. Ted Budd; Intern, Senator James DeMint.) [new]

Government entities lobbied: HOUSE OF REPRESENTATIVES; SENATE

`MMM` — Medicare/Medicaid

Legislative and regulatory issues affecting SMID rare disease biotech companies.

Lobbyists: JOHN MARTIN; KAREN STONE [new]; mr CHARLES PATRICK MICHAELS [new]